Drug intelligence / Profile preview

velo-np

Development stage
Unknown
Lead developer
British American Tobacco
Administration
Oral
01

Overview

**Velo-NP** is a modern oral nicotine pouch product containing tobacco-derived, pharmaceutical-grade nicotine but no tobacco leaf or plant matter other than extracted nicotine. It is placed between the gum and cheek to deliver nicotine without combustion or spitting and is designed as a potentially less harmful alternative to traditional smoking and smokeless tobacco[3][4][6]. Clinical and laboratory analyses show that Velo-NP delivers nicotine efficiently, with lower levels of toxicants compared to cigarettes and snus, reduced biomarkers of tobacco-related exposure, and an improved safety profile. Users in trials reported satisfactory nicotine delivery and reduced cigarette consumption over study periods, supporting its use in tobacco harm reduction strategies for adult smokers not ready to quit[1][3][5]. Velo-NP is marketed primarily by British American Tobacco subsidiaries and is part of the broader VELO and nicotine pouch portfolios[3][4].

Brand names
Velo-NP
Other names
Velo NP
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)

Beyond the preview

Go deeper on velo-np.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on velo-np.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call